EP1438323A4 - Adjuvanted meningococcus compositions - Google Patents
Adjuvanted meningococcus compositionsInfo
- Publication number
- EP1438323A4 EP1438323A4 EP02800481A EP02800481A EP1438323A4 EP 1438323 A4 EP1438323 A4 EP 1438323A4 EP 02800481 A EP02800481 A EP 02800481A EP 02800481 A EP02800481 A EP 02800481A EP 1438323 A4 EP1438323 A4 EP 1438323A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- meningococcus
- adjuvanted
- compositions
- meningococcus compositions
- adjuvanted meningococcus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Biological Depolymerization Polymers (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US254438 | 1988-10-06 | ||
US32692901P | 2001-10-03 | 2001-10-03 | |
US326929P | 2001-10-03 | ||
PCT/US2002/010869 WO2002080648A2 (en) | 2001-04-05 | 2002-04-05 | Mucosal boosting following parenteral priming |
WOPCT/US02/10869 | 2002-04-05 | ||
US37354702P | 2002-04-17 | 2002-04-17 | |
US373547P | 2002-04-17 | ||
US38067702P | 2002-05-13 | 2002-05-13 | |
US380677P | 2002-05-13 | ||
US25443802A | 2002-09-24 | 2002-09-24 | |
US0230423 | 2002-09-24 | ||
WOPCT/US02/30423 | 2002-09-24 | ||
PCT/US2002/031726 WO2003028661A2 (en) | 2001-10-03 | 2002-10-03 | Adjuvanted meningococcus compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1438323A2 EP1438323A2 (en) | 2004-07-21 |
EP1438323A4 true EP1438323A4 (en) | 2007-08-01 |
Family
ID=32601151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02800481A Withdrawn EP1438323A4 (en) | 2001-10-03 | 2002-10-03 | Adjuvanted meningococcus compositions |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1438323A4 (en) |
JP (1) | JP4522699B2 (en) |
CN (1) | CN100354297C (en) |
AU (1) | AU2002334844B2 (en) |
BR (1) | BR0213119A (en) |
CA (1) | CA2462646C (en) |
NZ (1) | NZ532274A (en) |
WO (1) | WO2003028661A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0115176D0 (en) | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
MXPA04011249A (en) * | 2002-05-14 | 2005-06-06 | Chiron Srl | Mucosal vaccines with chitosan adjuvant and meningococcal antigens. |
GB0302218D0 (en) | 2003-01-30 | 2003-03-05 | Chiron Sri | Vaccine formulation & Mucosal delivery |
SI2255826T1 (en) * | 2002-08-02 | 2016-07-29 | Glaxosmithkline Biologicals S.A. | Neisserial vaccine compositions comprising a combination of antigens |
US8034378B2 (en) | 2002-12-27 | 2011-10-11 | Novartis Vaccines And Diagnostics, Inc | Immunogenic compositions containing phospholipid |
ATE426412T1 (en) * | 2003-01-30 | 2009-04-15 | Novartis Vaccines & Diagnostic | ADJUVANT INFLUENZA VACCINE |
ES2411080T3 (en) | 2003-01-30 | 2013-07-04 | Novartis Ag | Injectable vaccines against multiple serogroups of meningococci |
US7731967B2 (en) | 2003-04-30 | 2010-06-08 | Novartis Vaccines And Diagnostics, Inc. | Compositions for inducing immune responses |
JP5557415B2 (en) | 2003-06-02 | 2014-07-23 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | Immunogenic compositions based on microparticles containing adsorbed toxoid and polysaccharide-containing antigens |
JP2007523173A (en) * | 2004-02-20 | 2007-08-16 | イデラ ファーマシューティカルズ インコーポレイテッド | Strong mucosal immune response induced by modified immunomodulatory oligonucleotides |
CA2588089C (en) * | 2004-11-15 | 2015-06-23 | Novartis Vaccines And Diagnostics Inc. | Immunogenic compositions containing anthrax antigen, biodegradable polymer microparticles, and polynucleotide-containing immunological adjuvant |
WO2006081576A2 (en) | 2005-01-28 | 2006-08-03 | Galenbio, Inc. | Immunologically active compositions |
ATE438385T1 (en) * | 2005-03-02 | 2009-08-15 | Secr Defence | PHARMACEUTICAL COMPOSITION |
EP3067048B1 (en) | 2007-12-07 | 2018-02-14 | GlaxoSmithKline Biologicals SA | Compositions for inducing immune responses |
CN101559225B (en) * | 2008-04-18 | 2012-07-11 | 北京生物制品研究所 | Meningococcus vaccine |
PL2863942T3 (en) * | 2012-06-21 | 2019-12-31 | Northwestern University | Peptide conjugated particles |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6239116B1 (en) * | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
CA2671261A1 (en) * | 1997-11-06 | 1999-05-20 | Novartis Vaccines And Diagnostics S.R.L. | Neisserial antigens |
BR9906927A (en) * | 1998-01-14 | 2001-11-20 | Chiron Spa | Neisseria meningitidis proteins |
NZ541361A (en) * | 1998-05-01 | 2008-04-30 | Inst Genomic Research | Neisseria meningitidis antigens and compositions relating to SEQ ID Nos:2916, 2918 and 2920 |
JP4601168B2 (en) * | 1998-07-29 | 2010-12-22 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | MICROPARTICLES HAVING ADSORPTION SURFACE, METHOD FOR MAKING THE SAME, AND USE |
EP1144998A3 (en) * | 1998-10-09 | 2002-08-07 | Chiron Corporation | Neisseria genomic sequences and methods of their use |
AU2457100A (en) * | 1999-02-26 | 2000-09-14 | Chiron S.P.A. | Enhancement of bactericidal activity of neisseria antigens with oligonucleotidescontaining cg motifs |
AU2875700A (en) * | 1999-02-26 | 2000-09-14 | Chiron Corporation | Microemulsions with adsorbed macromoelecules and microparticles |
MXPA01010924A (en) * | 1999-04-30 | 2002-05-06 | Chiron Spa | Conserved neisserial antigens. |
BR0108711A (en) * | 2000-02-28 | 2004-06-22 | Chiron Spa | Heterologous expression of neisserial proteins |
-
2002
- 2002-10-03 WO PCT/US2002/031726 patent/WO2003028661A2/en active IP Right Grant
- 2002-10-03 CA CA2462646A patent/CA2462646C/en not_active Expired - Fee Related
- 2002-10-03 BR BR0213119-6A patent/BR0213119A/en not_active IP Right Cessation
- 2002-10-03 NZ NZ532274A patent/NZ532274A/en not_active IP Right Cessation
- 2002-10-03 CN CNB028241282A patent/CN100354297C/en not_active Expired - Fee Related
- 2002-10-03 AU AU2002334844A patent/AU2002334844B2/en not_active Ceased
- 2002-10-03 JP JP2003531997A patent/JP4522699B2/en not_active Expired - Fee Related
- 2002-10-03 EP EP02800481A patent/EP1438323A4/en not_active Withdrawn
Non-Patent Citations (3)
Title |
---|
O'HAGAN D T ET AL: "POLY(LACTIDE-CO-GLYCOLIDE) MICROPARTICLES FOR THE DEVELOPMENT OF SINGLE-DOSE CONTROLLED-RELEASE VACCINES", ADVANCED DRUG DELIVERY REVIEWS, AMSTERDAM, NL, vol. 32, 1998, pages 225 - 246, XP000944990, ISSN: 0169-409X * |
SINGH M ET AL: "ADVANCES IN VACCINE ADJUVANTS", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 17, no. 11, November 1999 (1999-11-01), pages 1075 - 1081, XP000941305, ISSN: 1087-0156 * |
SINGH M ET AL: "Cationic microparticles are an effective delivery system for immunie stimulatory CpG DNA", PHARMACEUTICAL RESEARCH, NEW YORK, NY, US, vol. 18, no. 10, October 2001 (2001-10-01), pages 1476 - 1479, XP002976979, ISSN: 0724-8741 * |
Also Published As
Publication number | Publication date |
---|---|
CA2462646A1 (en) | 2003-04-10 |
JP4522699B2 (en) | 2010-08-11 |
BR0213119A (en) | 2004-12-28 |
EP1438323A2 (en) | 2004-07-21 |
CA2462646C (en) | 2013-02-12 |
JP2005526697A (en) | 2005-09-08 |
AU2002334844B8 (en) | 2003-04-14 |
WO2003028661A3 (en) | 2003-10-09 |
AU2002334844B2 (en) | 2007-08-02 |
CN1599746A (en) | 2005-03-23 |
CN100354297C (en) | 2007-12-12 |
WO2003028661A2 (en) | 2003-04-10 |
NZ532274A (en) | 2006-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL227966A0 (en) | Vaccine composition | |
EP1438074A4 (en) | Adjuvant compositions | |
GB0103170D0 (en) | Vaccine composition | |
GB0103171D0 (en) | Vaccine composition | |
HUP0301413A3 (en) | Vaccine compositions | |
PL368370A1 (en) | Glyphosate composition | |
IL188834A0 (en) | Novel vaccine composition | |
GB0129007D0 (en) | Adjuvanted antigenic meningococcal compositions | |
HUP0303942A3 (en) | Novel vaccine composition | |
EP1438323A4 (en) | Adjuvanted meningococcus compositions | |
HUP0400174A2 (en) | Lipid-polymer-conjugates compositions | |
PT1368456E (en) | Anti-bacterial vaccine compositions | |
GB0126266D0 (en) | Anthrax antigenic compositions | |
GB0126244D0 (en) | Oral compositions | |
GB0200763D0 (en) | Compositions | |
HUP0600303A2 (en) | Pentafluorpropane based compositions | |
EG23126A (en) | Novel fungicial compositions | |
ZA200401211B (en) | Antigenic compositions | |
GB0105622D0 (en) | Compositions | |
GB0114532D0 (en) | Novel compositions | |
GB0000438D0 (en) | Dental compositions | |
GB0103328D0 (en) | Compositions | |
GB0018230D0 (en) | Dental compositions | |
GB0112345D0 (en) | Compositions | |
GB0101392D0 (en) | Compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040420 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC. |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20070704 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 39/385 20060101ALI20070628BHEP Ipc: A61K 39/095 20060101ALI20070628BHEP Ipc: A61K 39/02 20060101AFI20070628BHEP |
|
17Q | First examination report despatched |
Effective date: 20101020 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20140501 |